SEI Investments’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
JT
PA
NAMI
SEI Investments's TVTX Position: Q2 2026 in Review
SEI Investments reduced its Travere Therapeutics (TVTX) stake by 14% in Q2 2026, selling an estimated $1.05M and leaving 142,858 shares worth $8.12M. The position accounts for 0.01% of the portfolio, ranked #1236.
SEI Investments first reported a position in TVTX in Q3 2015 and has held it in 18 quarters since. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- SEI Investments held 142,858 shares of Travere Therapeutics worth $8.12M as of Q2 2026.
- SEI Investments sold 23,619 Travere Therapeutics shares in Q2 2026, an estimated $1.05M.
- Travere Therapeutics made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1236 holding.
- SEI Investments first reported a position in Travere Therapeutics in Q3 2015 and has held it in 18 quarters since.
- 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.